Related Experiment Videos
Effect of occlusion on the visual evoked response in amblyopia
Insights
Visual Evoked Response (VER) testing reveals differences in children compared to adults. Amblyopic eyes show delayed VER, and occlusion therapy can temporarily alter responses, impacting visual development.
Area of Science:
- Ophthalmology
- Neuroscience
- Pediatric Vision
Background:
- Understanding visual development in children is crucial for diagnosing and treating visual impairments.
- Visual Evoked Response (VER) is a key electrophysiological tool to assess visual pathway function.
- Amblyopia and occlusion therapy are common considerations in pediatric ophthalmology.
Purpose of the Study:
- To establish normal Visual Evoked Response (VER) values in children aged 4-11 years.
- To compare pediatric VER findings with adult values and analyze differences.
- To investigate the impact of amblyopia and occlusion therapy on VER parameters.
Main Methods:
- Recorded Visual Evoked Responses (VERs) in a cohort of children aged 4 to 11 years.
- Compared obtained VER values with established adult normative data.
- Analyzed VER characteristics (time to peak, amplitude) in amblyopic eyes and eyes treated with occlusion therapy.
Main Results:
- Normal VER values in children aged 4-11 years show slight but significant differences from adult values, notably an increased P1 time to peak.
- Amblyopic eyes exhibit increased time to peak and reduced amplitude, correlating with visual acuity and binocularity loss.
- Occlusion therapy increases VER time to peak in the treated (better) eye, often normalizing post-therapy, though prolonged occlusion may cause lasting changes.
Conclusions:
- Pediatric VER values differ from adult norms, particularly in the time to peak.
- VER effectively quantifies visual pathway dysfunction in amblyopia and reflects the effects of occlusion therapy.
- While VER typically normalizes after occlusion, prolonged treatment can lead to persistent alterations.
Abstract:
Average normal values for the VER were obtained in children aged 4 to 11 years. There are slight but significant differences between the values obtained and those found in adults (an increase in the time to peak of P1). In amblyopic eyes the time to peak is increased, and the amplitude reduced, roughly in proportion to the loss of visual acuity and binocularity. The VER is normal in the better eyes of children who have never been treated by occlusion therapy. Occlusion increases the time to peak of the VER, both in serial studies on individuals, and in lateral population studies, so that the response of the better eye is delayed beyond that of the amblyopic eye. After the end of occlusion, the VER change usually returns to normal. In a subgroup of patients with prolonged occlusion, the changes had not completely reversed one year later. In children in whom occlusion therapy had improved visual acuity, the VER returned towards normal.